None of the microscopic readings for women with a vaginal pH < 5.0 revealed cases of either moderate or severe AV (modified scores, excluding the criterion related to toxic leukocytes); none of the 137patients with vaginal pH > =5.0 presented severe AV and less than 5% presented moderate AV.
Infants from 0 to 6 months old, admitted in PICU for severe bronchiolitis (modified Wood score >3), were randomized into two groups: "HFNC" (2 l/kg/min) and "nCPAP" (6 cm H2O) during 24 h.
Δ4-androstenedione and dehydroepiandrosterone sulfate levels were associated with poor outcome in the univariate analysis, that is, combined severe handicap (modified Rankin Scale ≥4) and death, 1 month poststroke, although this was not significant in the multivariate analysis.
Patients: Eight patients (mean age, 55.1 ± 12.1yr; mean duration to block, 4.4 ± 3.7mo) with chronic hemiplegia and severe spasticity (modified Ashworth scale [MAS] score < 2) secondary to cerebrovascular accidents (n = 5) and traumatic brain injuries (n = 3).
Progression to severe malaria (modified WHO 2010 criteria 21 ).
In sensitivity analysis, we compared the genotypes in those without AKI to those with severe AKI (modified AKIN stage 2 and 3).
Outcomes were incremental cost per incremental: QALY, survivor, and patient free from death or severe disability (modified Rankin scale score < 4) at three months and 14 days post stroke.
However, on average, a higher score was also observed in the most affected lung area (MA-method) from aerosolized animals) indicating the development of a more severe fibrosis (modified Ashcroft score between 4 and 5) upon using this route of administration.
It has been reported that severe sepsis modifies amikacin kinetics by increasing its apparent volume of distribution of the central compartment and decreasing its elimination rate, probably as a consequence of leaky capillaries and organ failure [ 5– 7].
If a full range of outcomes was presented, we considered a Glasgow Outcome Scale (GOS) score of 1 to 3 (death, vegetative state or severe disability), a modified Rankin Scale (mRS) score of 4 to 6 (moderately severe disability, severe disability, death) or a cerebral performance category (CPC) of 3 to 5 (severe disability, coma or vegetative state, death) to represent poor outcomes.
